Oneview Healthcare PLC (ASX:ONE)

Australia flag Australia · Delayed Price · Currency is AUD
0.1600
-0.0050 (-3.03%)
May 18, 2026, 3:41 PM AEST
Market Cap134.24M -39.1%
Revenue (ttm)21.12M +21.3%
Net Income-22.16M
EPS-0.04
Shares Out838.98M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume268,307
Average Volume153,431
Open0.1650
Previous Close0.1650
Day's Range0.1550 - 0.1650
52-Week Range0.1550 - 0.4100
Beta0.76
RSI32.53
Earnings DateMay 20, 2026

About Oneview Healthcare

Oneview Healthcare PLC develops and sells software services for the healthcare sector in Ireland, the United States, Australia, the Middle East, and Asia. The company provides patient experience, care team experience, and health system and hospital solutions; and system integrations for HER/EMP/PAS, virtual care, interpretations, middleware, clinical communications, dietary, IoT: RTLS and building automation, patient education and portals, entertainment and gaming, calming and distraction, and consumer streaming and social. It also offers secur... [Read more]

Sector Healthcare
Founded 2008
Employees 99
Stock Exchange Australian Securities Exchange
Ticker Symbol ONE
Full Company Profile

Financial Performance

In 2025, Oneview Healthcare's revenue was 12.00 million, an increase of 21.28% compared to the previous year's 9.90 million. Losses were -12.59 million, 16.2% more than in 2024.

Financial numbers in EUR Financial Statements

News

Oneview Healthcare Earnings Call Transcript: H2 2025

Revenue grew 21% in 2025, driven by U.S. expansion and new product launches, while gross margin declined to 64% due to revenue mix. Cost efficiencies and AI-driven innovation are expected to support further growth and margin stability in 2026.

3 months ago - Transcripts

Oneview Healthcare Earnings Call Transcript: H1 2025

Revenue grew 36% year-over-year in H1 2025, driven by strong U.S. performance and new deployments, though gross margin declined due to hardware mix. Restructuring and AI innovation position the company for improved efficiency and growth in H2 2025.

9 months ago - Transcripts